Workflow
铀钼等
icon
Search documents
中国铀业今日申购,发行市盈率为27.06倍!单一账户申购上限为5.2万股,顶格申购需配市值52万元
Ge Long Hui· 2025-11-21 04:59
Core Viewpoint - China Uranium Industry has initiated its subscription process, offering a total of 248 million shares at a price of 17.89 yuan per share, with an earnings per share (EPS) ratio of 27.06 times [1] Group 1: Subscription Details - The total number of shares issued is 248 million, with 52.118 million shares available for online subscription [1] - The subscription code is 001280, and the maximum subscription limit for a single account is 52,000 shares [1] - Subscriptions must be in multiples of 500 shares, requiring a minimum market value of 520,000 yuan for the highest subscription [1] Group 2: Company Operations - The company specializes in the comprehensive utilization of natural uranium and radioactive associated mineral resources [1] - Its main activities include the mining, sales, and trade of natural uranium resources, as well as the comprehensive utilization and sales of products like monazite and uranium-molybdenum [1]
中国铀业主板IPO披露第二轮审核问询函回复
Bei Jing Shang Bao· 2025-08-08 13:55
Group 1 - The core viewpoint of the article is that China Uranium Corporation is progressing with its IPO process, having responded to the second round of inquiries from the Shenzhen Stock Exchange [1] - China Uranium focuses on the comprehensive utilization of natural uranium and radioactive associated mineral resources, primarily engaging in the mining, sales, and trade of natural uranium resources, as well as the utilization and sales of products like monazite and uranium-molybdenum [1] - The company aims to raise approximately 4.11 billion yuan through its IPO, which will be allocated to natural uranium production capacity projects, comprehensive utilization projects of radioactive associated mineral resources, and to supplement working capital after deducting issuance costs [1] Group 2 - The IPO application was accepted on June 20, 2024, and entered the inquiry stage on July 18, 2024 [1] - In the second round of inquiries, the company faced questions regarding related party transactions with China National Nuclear Corporation, post-IPO performance, and gross margin issues [1]